Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 64

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 2
Chunk 64
---
30, 2025, no director or officer of the Company adopted, modified, or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation
S-K.

ITEM
6. EXHIBITS

    Exhibit
    No.
     
    Description

    31.1*
     
    Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act*

    31.2*
     
    Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act*

    32.1*
     
    Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**

    32.2*
     
    Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**

    101.INS*
     
    Inline
    XBRL Instance Document*
  
    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema Document*
  
    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase Document*
  
    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase Document*
  
    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Label Linkbase Document*
  
    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase Document*
  
    104*
     
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)*

*
Filed herewith.

**
Furnished herewith.

34

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    Jupiter
    Neurosciences, Inc.

    Date:
    November 14, 2025
    /s/
    Christer Rosén

    Christer
    Rosén

    Chief
    Executive Officer

    (Principal
    Executive Officer)

    Date:
    November 14, 2025
    /s/
    Saleem Elmasri

    Saleem
    Elmasri

    Chief
    Financial Officer

    (